KODIAK SCIENCES INC. Payments for Derivative Instrument, Investing Activities
KODIAK SCIENCES INC. (KOD) reported Payments for Derivative Instrument, Investing Activities of $144.00 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-15.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsForDerivativeInstrumentInvestingActivities · last filed 2024-05-15
- KODIAK SCIENCES INC. payments for derivative instrument, investing activities for the quarter ending 2024-03-31 was $144.00K.
- KODIAK SCIENCES INC. payments for derivative instrument, investing activities for the quarter ending 2023-03-31 was $0.00.
| Period end | Payments for Derivative Instrument, Investing Activities 3 month |
|---|---|
| 2024-03-31 | $144.00K 10-Q · filed 2024-05-15 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |